The Trump administration is shutting down a federally designated organ procurement organization that allegedly pursued organ retrieval from patients who were still alive, a failure HHS says the Biden administration ignored for years.
HHS Secretary Robert F. Kennedy Jr. announced Wednesday that the Department of Health and Human Services has begun decertifying Network for Hope, the organ procurement organization serving nearly 7 million people across Kentucky and parts of Indiana, Ohio, and West Virginia. The move follows a federal review spanning 2021 through 2024 that Just the News reported uncovered abnormalities in 103 of 351 cases, 29.3 percent, in which organ donation was authorized but never completed.
Of those 103 cases, 73 involved patients who showed signs of neurological incompatibility with organ donation. In plain terms: federal investigators found evidence that dozens of people marked as donors may not have been dead when the procurement process began.
Kennedy put a name and a face to the data. At the announcement, he described the case of a man identified in supporting reports as Anthony Thomas "TJ" Hoover II, who suffered a drug overdose in 2021. His family was told he would not recover. Network for Hope moved forward with organ retrieval, but attending physicians stopped the surgery because they believed Hoover was still alive.
Kennedy told attendees that Hoover "showed signs of awareness while on the operating table, about to have his organs removed," and that "physicians refused to proceed with the organ recovery because they believed that he was still alive." Hoover is alive today because those doctors refused to continue.
His sister, Donna Rohrer, described the scene in stark terms. She told the Washington Examiner:
"My brother almost thrashing, crying, and grabbing the doctor's hands to stop him."
That account alone would be enough to justify scrutiny. But Hoover's case was not an isolated incident. Federal investigators found that Network for Hope ignored signs of alertness in more than 70 patients, with over 100 cases flagged for concerning features across the four-year review period.
Kennedy framed the decertification as a correction the previous administration should have made years ago. In a statement released alongside the announcement, he said:
"Under the Biden administration, HHS failed to hold organizations accountable when serious patient concerns emerged. Today we are restoring that accountability. We will not tolerate organizations that compromise patient safety or betray the trust of donors or their families."
The timeline supports the charge. The HRSA review covered cases from 2021 through 2024, the entirety of the Biden presidency. If the Health Resources and Services Administration was documenting these abnormalities in real time, the question becomes why the previous administration took no decertification action despite a nearly 30 percent deficiency rate in the cases it examined.
That kind of institutional passivity, regulators identifying problems and then declining to act, is a pattern familiar to anyone watching how federal agencies have handled accountability in recent years. Whether the issue is public trust in government institutions or oversight of life-and-death medical programs, the result is the same: ordinary people bear the consequences of elite inaction.
Network for Hope, headquartered in Cincinnati and Louisville, has announced plans to appeal the decertification. The organization serves a vast region and warns that the federal action will harm the more than 3,000 people currently waiting for transplants in its service area.
Tiffany Mattingly, the organization's chief engagement officer and vice president of Clinical Strategies, struck a conciliatory tone in remarks to NPR.
"Our local hospitals are hopeful that any issues identified by HHS can be resolved promptly, so that the Network for Hope can return to its full focus to their critical life-saving mission."
Area hospitals, for their part, sought to reassure patients. NPR's affiliate WVXU reported that local hospitals do not anticipate an immediate impact on patient care, transplant services, or organ donation practices. But the longer-term picture remains unclear. If the appeal fails and Network for Hope loses its federal designation, someone else will have to serve those 7 million people, and the 3,000 patients on the waiting list cannot afford a gap in coverage.
The tension between accountability and continuity is real. But it is not an argument for looking the other way when a procurement organization is flagged for initiating organ retrieval on patients who may still be alive. The stakes run in both directions.
This is not the first time the Trump administration has moved against an organ procurement organization. The Washington Examiner noted that HHS decertified the University of Miami Health System's organ procurement organization in September 2025, making Network for Hope the second OPO to lose its federal designation in less than a year.
The broader organ donation system remains critical. More than 100,000 Americans sit on the national transplant waiting list. Roughly 13 people die each day waiting for an organ. The system performed a record 49,064 transplants in 2025 from 23,788 donors, and more than 170 million Americans are registered as organ, eye, and tissue donors.
Those numbers underscore why public trust in the procurement process matters so much. Every scandal, every case of a patient nearly carved open while still conscious, erodes the willingness of families to consent to donation. The system depends on trust. Organizations like Network for Hope, if the federal findings hold up, did more to damage that trust than any bureaucratic disruption from decertification ever could.
The broader political landscape reflects a similar dynamic. Across Senate races and policy fights, Democrats have banked on institutional credibility even as the institutions themselves have failed to deliver. Whether the arena is healthcare oversight, border enforcement, or progressive social policy, the pattern is the same: problems documented, action deferred, and the people most affected left to absorb the cost.
Several important questions remain unanswered. The HRSA review found 103 cases with abnormalities, but only 73 involved neurological incompatibility. What happened in the other 30 cases? The federal review has not publicly disclosed whether the 29.3 percent deficiency rate is unique to Network for Hope or consistent with a national baseline, a distinction that would determine whether this is a rogue operator or a systemic problem.
The precise legal mechanism for decertification, and the timeline for Network for Hope's appeal, also remain unclear. And while Kennedy presented TJ Hoover's case as a centerpiece of the announcement, the specific hospital or institution involved in that 2021 incident has not been publicly identified in the available reporting.
What is clear is that for at least four years, a federally designated organization responsible for organ procurement in a four-state region was flagged for serious safety failures, and nothing happened until the current administration acted. The Biden-era HHS had the same data. It chose not to move.
Progressive leaders in Congress have spent recent years lecturing the public about the sanctity of government expertise and the importance of trusting federal agencies. Figures like Abdul El-Sayed and others on the left have built careers on the premise that more government oversight produces better outcomes. Network for Hope's record suggests the opposite: the oversight existed, the data was collected, and the previous administration still failed to protect patients.
When the government's own review finds that nearly one in three flagged cases involved a patient who may not have been dead, accountability is not optional. It is the bare minimum.
